Gregory M. Lucas, MD PhD
Gregory M. Lucas, MD PhD
Johns Hopkins University School of Medicine
Verified email at
Cited by
Cited by
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions
GM Lucas, RE Chaisson, RD Moore
Annals of internal medicine 131 (2), 81-87, 1999
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection
GM Lucas, LW Cheever, RE Chaisson, RD Moore
JAIDS Journal of Acquired Immune Deficiency Syndromes 27 (3), 251-259, 2001
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic
GM Lucas, KA Gebo, RE Chaisson, RD Moore
Aids 16 (5), 767-774, 2002
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases …
GM Lucas, MJ Ross, PG Stock, MG Shlipak, CM Wyatt, SK Gupta, MG Atta, ...
Clinical Infectious Diseases 59 (9), e96-e138, 2014
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study
GM Lucas, JA Eustace, S Sozio, EK Mentari, KA Appiah, RD Moore
Aids 18 (3), 541-546, 2004
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study
FL Altice, RD Bruce, GM Lucas, PJ Lum, PT Korthuis, TP Flanigan, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 56, S22-S32, 2011
Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races
GM Lucas, B Lau, MG Atta, DM Fine, J Keruly, RD Moore
The Journal of infectious diseases 197 (11), 1548-1557, 2008
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes
GM Lucas, N Lechtzin, DW Puryear, LL Yau, CW Flexner, RD Moore
Clinical infectious diseases 26 (5), 1127-1133, 1998
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy
GM Lucas, M Griswold, KA Gebo, J Keruly, RE Chaisson, RD Moore
American Journal of Epidemiology 163 (5), 412-420, 2006
Buprenorphine use: the international experience
MP Carrieri, L Amass, GM Lucas, D Vlahov, A Wodak, GE Woody
Clinical Infectious Diseases 43 (Supplement 4), S197-S215, 2006
Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial
LR Metsch, DJ Feaster, L Gooden, T Matheson, M Stitzer, M Das, MK Jain, ...
JAMA 316 (2), 156-170, 2016
End-stage renal disease among HIV-infected adults in North America
AG Abraham, KN Althoff, Y Jing, MM Estrella, MM Kitahata, CW Wester, ...
Clinical Infectious Diseases 60 (6), 941-949, 2015
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
B Spire, GM Lucas, MP Carrieri
International Journal of Drug Policy 18 (4), 262-270, 2007
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups
GM Lucas, BA Mullen, PJ Weidle, S Hader, ME McCaul, RD Moore
Clinical infectious diseases 42 (11), 1628-1635, 2006
Observations on a cohort of HIV-infected patients undergoing native renal biopsy
AR Berliner, DM Fine, GM Lucas, MH Rahman, LC Racusen, PJ Scheel, ...
American journal of nephrology 28 (3), 478-486, 2008
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
SH Mehta, GM Lucas, LB Mirel, M Torbenson, Y Higgins, RD Moore, ...
Aids 20 (18), 2361-2369, 2006
Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven
GM Lucas
Journal of Antimicrobial Chemotherapy 55 (4), 413-416, 2005
End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004
GM Lucas, SH Mehta, MG Atta, GD Kirk, N Galai, D Vlahov, RD Moore
Aids 21 (18), 2435-2443, 2007
Cerebral asymmetry and handedness.
LE White, G Lucas, A Richards, D Purves
Nature; Nature, 1994
An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002
RD Moore, JC Keruly, KA Gebo, GM Lucas
JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (2), 195-198, 2005
The system can't perform the operation now. Try again later.
Articles 1–20